Vial, a global tech-first CRO providing next-generation clinical trial management services, announced its VP of Business Development, Daniel Gallagher, will be attending and speaking at the Precision in Clinical Trials (PCT) Summit in Boston, MA.
The conference will consist of fireside chats, brainstorming sessions, and corporate panel discussions. There will be a wide array of high-interest topical panels, including discussions of technological innovation, life science and diagnostic tools, therapeutics, healthcare delivery, and the evolving political and regulatory landscape.
Also Read: Thrive Acquires Canadian-based Storagepipe
During the first day of PCT, Monday, May 1st, 2023, from 4:25p to 4:50p (EST), Mr. Gallagher will provide a featured talk on the topic of, Technological Innovation Discussion: Reimagining Clinical Trials, where he will touch on how technology is impacting the clinical research industry and how Vial has reimagined clinical trials through their next-generation technology platform, innovative approach, and fixed-fee pricing model to create a CRO built for sponsors.
“I’m excited to attend PCT and have the opportunity to discuss the ways in which technological innovation is transforming the landscape of clinical trials and how they are conducted. New technologies and methodologies are making it possible to deliver trials to sponsors more efficiently, with greater precision, and at a lower cost, which is Vial’s mission,” said Daniel Gallagher, VP of Business Development Vial.
SOURCE: PR Newswire